Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in France
81 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleBeamion BCGC-1: A study to find a suitable dose of zongertinib used alone and in combination with other treatments to test whether it helps people with different types of HER2+ cancer that has spread
- Where
- Bordeaux, Caen Cedex 5, Dijon, Lyon, Marseille, Paris, Rennes Cedex, Saint-Herblain Cedex, Strasbourg, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 181 worldwide
- Run by
- Boehringer Ingelheim International GmbH
See details and how to join2023-509566-38-00 - Phase 3Taking peopleQuality of Life After Billroth II or Roux-en-Y for Gastric Cancer
- Where
- Paris
- Age
- 18 years and over
- People
- 250
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06768164 - Phase 2Taking peoplePhase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
- Where
- Amiens, Annecy, Avignon, Bayonne, Besançon, Beuvry, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Nancy, Paris, Perpignan, Poitiers, Reims, Rennes, Rouen, Saint-Herblain, St-Malo, Strasbourg, Tours, Villeurbanne
- Age
- 70 years and over
- People
- 95
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT07205731 - No phaseTaking peopleEvaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer
- Where
- Pessac
- Age
- 18 years and over
- People
- 670
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07584577 - Phase 2Not yet taking people in FranceStaging of gastric cancers by PET-FAPI
- Where
- Montpellier Cedex 5, Pessac Cedex
- Age
- 18 years and over
- People
- 40
- Run by
- Centre Hospitalier Universitaire De Bordeaux
See details and how to join2025-524434-25-00 - Phase 3Taking peopleStudy aiming to compare the survival of patients with locally advanced or metastatic MSI/dMMR Esogastric adenocarcinomas treated by a combination of Immune checkpoint inhibitors (botensilimab + balstilimab) versus the standard of care (FOLFOX/XELOX + nivolumab)
- Where
- Avignon Cedex 9, Brest, Caen Cedex 5, Clermont-Ferrand, Dijon, Lyon, Marseille, Paris, Poitiers
- Age
- 18 years and over
- People
- 132
- Run by
- Centre Leon Berard
See details and how to join2023-506291-28-00 - Phase 2Taking peopleStudy Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
- Where
- Lyon
- Age
- 18 years and over
- People
- 60
- Run by
- Centre Leon Berard
See details and how to joinNCT06385691 - Phase 4Taking peopleETCABio - Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 140
- Run by
- Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 - Phase 1Taking peopleStudy to evaluate the safety of MAQ-001 as monotherapy and combination therapy in patients with advanced cancers
- Where
- Lyon, Rennes Cedex, Toulouse Cedex 9, Villejuif Cedex
- Age
- 18 years and over
- People
- 30
- Run by
- MabQuest Therapeutics S.A.
See details and how to joinNCT06514651 · EU 2023-507774-41-00 - No phaseNot yet taking people in FranceA Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer
- Where
- Lille
- Age
- 18 years and over
- People
- 266 worldwide
- Run by
- University Hospital, Antwerp
See details and how to joinNCT07455422 - No phaseTaking peopleA Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
- Where
- Lille
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- University Hospital, Antwerp
See details and how to joinNCT06523374 - No phaseNot yet taking people in FranceTotally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
- Where
- Lille
- Age
- 18 years to 80 years
- People
- 327
- Run by
- University Hospital, Lille
See details and how to joinNCT07408999 - Phase 1/2Taking peoplePhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
- Where
- Lyon, Villejuif
- Age
- 18 years and over
- People
- 43 worldwide
- Run by
- One-carbon Therapeutics AB
See details and how to joinNCT07151040 · EU 2024-519639-40-00 - No phaseNot yet taking people in FranceEvaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer Screening
- Where
- Nantes
- Age
- 50 years to 74 years
- People
- 100
- Run by
- Nantes University Hospital
See details and how to joinNCT07323186 - Phase 2Taking peopleSafety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
- Where
- Amiens Cedex 1, Besancon Cedex, Bordeaux, Cholet, Lille Cedex, Lyon, Montpellier Cedex 5, Paris, Paris Cedex 12, Pierre-Bénite, Poitiers, Reims, Reims Cedex, Saint-Priest-en-Jarez, Trévenans, Vandouvre Les Nancy
- Age
- 18 years and over
- People
- 73
- Run by
- UNICANCER
See details and how to joinNCT06245356 · EU 2023-508724-35-00 - Phase 2Taking peopleOptimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
- Where
- Villejuif
- Age
- 18 years and over
- People
- 400
- Run by
- UNICANCER
See details and how to joinNCT07259226 - Phase 2Taking peopleFirst-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
- Where
- Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Cholet, Clermont-Ferrand, Créteil, Dijon, La Tronche, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Saint-Mandé, St-Malo, Strasbourg, Tours, Vandœuvre-lès-Nancy, Villejuif, Villeurbanne
- Age
- 18 years and over
- People
- 120
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT06253611 - No phaseTaking peopleBiomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 80
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT02491840 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Brest Cedex 2, Lille, Lyon, Marseille, Paris Cedex 18, Rennes, Villejuif
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleCirculating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer
- Where
- Boulogne-Billancourt, Clichy, Le Kremlin-Bicêtre, Paris
- Age
- 18 years and over
- People
- 2,500
- Run by
- Institut Pasteur
See details and how to joinNCT05854368 - No phaseTaking peopleFluorescence Image Guided Foregut Surgery
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 60
- Run by
- IHU Strasbourg
See details and how to joinNCT04734821 - Phase 2CompletedEvaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma
- Where
- Angers, Bordeaux, Creteil, Dijon, Lille, Lyon, Marseille, Nantes, Nice Cedex 2, Paris, Paris Cedex 12, Reims, Reims Cedex, Rouen Cedex, Saint-Herblain, Tours Cedex 9, Vandoeuvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 120
- Run by
- Centre Leon Berard
See details and how to joinNCT06933966 · EU 2023-509227-41-00 - No phaseNot yet taking people in FranceIn-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients
- Where
- Marseille
- Age
- 18 years and over
- People
- 640
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06827639 - Phase 3Not yet taking people in FrancePROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
- Where
- Lyon, Nice, Paris
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- University of Aarhus
See details and how to joinNCT05055648 - No phaseNot yet taking people in FranceInteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
- Where
- Brest
- Age
- 18 years to 85 years
- People
- 250 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT04842916